Profitelligence Profitelligence · Filing Ledger Open A research →

Form 8-K/A · Current Report · Filed 2024-05-24

Agilent Technologies Announces CEO Retirement and Appointment of New CEO

On May 1, 2024, Agilent Technologies, Inc.

Filer
Agilent Technologies Inc. A · NYSE
Filed
Accession
0001193125-24-146578
CIK
0001090872
Signal
High impactHealthcare

Details

announced the retirement of Michael R. McMullen as President and CEO and the appointment of Padraig McDonnell as the new CEO. The Board also approved an annual base salary of $1,075,000, with a target performance bonus of 125%, and equity awards totaling $3,300,000 for McDonnell, effective from June 1, 2024.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

CEO Resignation New CEO Appointed Executive Compensation Detail
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$150.55

Next session

-1.6%

Since filing

-8.1%

Latest close

$138.37

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from A reporting the same item, with the next session's move:

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another A filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts